XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities    
Net loss $ (2,306,420) $ (891,076)
Adjustment to reconcile net loss to net cash used in operating activities:    
Depreciation 64,543 83,598
Loss on extinguishment of convertible notes 934,257
Stock-based compensation 218,944 18,923
Change in fair value of convertible notes 195,962
Changes in operating assets and liabilities:    
Accounts receivable, net (25) (5,653)
Other receivables 73,851 80,969
Prepaid expenses (270,150) 2,354
Inventory (5,704) 81,178
Accounts payable (94,674) 9,448
Accrued expenses 166,445 234,396
Deferred revenue   (25,000)
Net cash used in operating activities (1,022,971) (410,863)
Cash Flows from Investing Activities    
Purchase of equipment (5,250)
Cash Flows from Financing Activities    
Proceeds from issuance of units, gross 13,009,621
Proceeds from issuance of common stock to underwriters, gross 801,362  
Payment for issuance costs of units and common stock (1,558,193)
Proceeds from issuance of non-convertible promissory notes 415,000
Proceeds from issuance of convertible notes 250,000
Settlement of convertible notes (141,884)
Proceeds from loan payable – related party 140,000
Payment of loan payable – related party (166,000) (10,000)
Net cash provided by financing activities 12,334,906 405,000
Net change in cash and cash equivalents 11,306,685 (5,863)
Cash and cash equivalents, beginning of period 5,863
Cash and cash equivalents, end of period 11,306,685
Supplemental disclosure of cash flow information and non-cash financing transactions    
Conversion of notes at initial public offering into common stock 3,222,206  
Issuance costs in accounts payable 68,982  
Fair value of warrants for common stock issued to underwriters 1,647,076
Conversion of preferred stock par value to common stock and additional paid-in capital $ 58